This is an overview of some stocks which made the headlines on Thursday, February 3, during trading at midday.

Meta — The Facebook parent company’s stock tanked 25%, wiping out more than $200 million in market cap, after Meta reported weaker than expected earnings and user numbers for the fourth quarter. Facebook issued disappointing revenue guidance. It stated that Apple’s privacy policy, as well as TikTok’s growth, were hurting its advertising businesses.

Spotify — The music streaming stock dropped 16% after its user growth guidance for the first quarter failed to impress Wall Street. Spotify claimed it had 418 millions active users in the first quarter. That figure is approximately consistent with StreetAccount estimates by FactSet. However, the company reported. higher revenue and a smaller loss per share than expected for the fourth quarterHowever, it is also involved in a scandal over its exclusive relationship to podcast host Joe Rogan.

Pinterest, Snap, Twitter — Shares of social media companiesAfter Facebook’s parent Meta Platforms revealed lower than expected users during the fourth quarter, Snap fell 21% Snap sunk 21%. Pinterest dropped by 9% while Twitter lost about 6%.

T-Mobile — Shares of the telecom company jumped nearly 10% after the company issued rosy guidance. According to the company, free cash flow is expected to increase by 30% annually in 2022. T-Mobile’s fourth-quarter revenue estimate was not accurate, however.

Merck — The pharmaceutical stock dropped more than 3% after Merck’s fourth-quarter earnings report. StreetAccount reports that while the earnings and revenue estimates were higher than expected, full-year guidance for Merck fell below expectations.

McKesson — The medical supply stock jumped more than 4% after McKesson beat estimates on the top and bottom lines for its fiscal third quarter and delivered upbeat guidance. McKesson revenues increased 10% year-over year due to pharmaceutical growth.

DXC Technology — The information technology stock surged 13% after the company delivered a slight earnings beat for its fiscal third quarter. DXC stated that the company planned to invest $1 billion in stock buybacks within the next year.

Honeywell — After a quarter-quarter revenue loss due to supply chain problems, shares of Honeywell fell over 5% and hit a 52-week high. Refinitiv also revealed Honeywell’s adjusted quarterly earnings of $2.09 a share. This beat estimates by just a penny.

Align Technology — The dental products stock shed 1.5% despite beating estimates for earnings and revenue. The company published results on Wednesday. Piper Sandler, an investment firm, stated in a note that the stock could have suffered from weak Invisalign results and poor margin guidance.

Eli Lilly — Shares of the pharmaceutical giant ticked 2.7% lower despite the company beating on the top and bottom lines of its quarterly results. Sales of Trulicity and Covid-19 drugs boosted Eli Lilly’s earnings.

Biogen — Shares of the biotech company dipped more than 2% despite the company beating estimates on the top and bottom line for the fourth quarter. According to StreetAccount, FactSet, the company’s revenue and earnings guidance for 2022 was below estimates.